Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000908699 | SCV000526852 | benign | not provided | 2019-05-17 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 24074368) |
Labcorp Genetics |
RCV000908699 | SCV001053476 | benign | not provided | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000908699 | SCV004148846 | likely benign | not provided | 2024-07-01 | criteria provided, single submitter | clinical testing | FAT4: BP4, BS2 |
Breakthrough Genomics, |
RCV000908699 | SCV005302756 | benign | not provided | criteria provided, single submitter | not provided | ||
Genome Diagnostics Laboratory, |
RCV000908699 | SCV001809317 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000908699 | SCV001969653 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV003972639 | SCV004793784 | likely benign | FAT4-related disorder | 2019-06-24 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |